Compare NOG & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOG | NEOG |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | 64 | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2000 | 1995 |
| Metric | NOG | NEOG |
|---|---|---|
| Price | $21.28 | $10.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $31.14 | $10.67 |
| AVG Volume (30 Days) | ★ 3.9M | 1.9M |
| Earning Date | 04-28-2026 | 04-09-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $2,475,723,000.00 | $894,661,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | ★ N/A | $510.25 |
| Revenue Growth | ★ 11.23 | N/A |
| 52 Week Low | $17.18 | $4.56 |
| 52 Week High | $31.17 | $11.43 |
| Indicator | NOG | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 60.14 |
| Support Level | $20.57 | $8.82 |
| Resistance Level | $22.86 | $10.30 |
| Average True Range (ATR) | 0.70 | 0.39 |
| MACD | 0.47 | 0.08 |
| Stochastic Oscillator | 97.74 | 78.22 |
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.